Effectiveness of novel β-lactams for pseudomonas aeruginosa infection: A systematic review and meta-analysis. | 2024 | American Journal of Infection Control |
Comparing novel antibiotics and carbapenems for complicated intra-abdominal infections: A systematic review and meta-analysis of randomized controlled trials. | 2023 | International Journal of Antimicrobial Agents |
New antimicrobials for the treatment of neonatal sepsis caused by multi-drug-resistant bacteria: A systematic review. | 2023 | Antibiotics |
Comparative efficacy and safety of non-polymyxin antibiotics against nosocomial pneumonia, complicated intra-abdominal infection, or complicated urinary tract infection: A network meta-analysis of randomised clinical trials. | 2023 | Journal of Global Antimicrobial Resistance |
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: A systematic review and meta-analysis of clinical studies. | 2023 | Expert Review of Anti-infective Therapy |
Efficacy, safety, and tolerability of antimicrobial agents for complicated intra-abdominal infection: A systematic review and network meta-analysis. | 2023 | BioMed Central Infectious Diseases |
Global evaluation of the antibacterial activity of ceftolozane/tazobactam against ESBLs-producing Escherichia coli and Klebsiella pneumoniae: A systematic review and meta-analysis. | 2023 | Therapeutic Advances in Infectious Disease |
A meta-analysis on clinical outcomes of ceftolozane versus piperacillin in combination with tazobactam in patients with complicated urinary tract infections. | 2022 | BioMed Research International |
Ceftolozane/tazobactam for the treatment of bacteremia: A systematic literature review (SLR). | 2022 | Annals of Clinical Microbiology and Antimicrobials |
Real-world use of ceftolozane/tazobactam: A systematic literature review. | 2021 | Antimicrobial Resistance and Infection Control |
Ceftolozane/tazobactam for resistant drugs Pseudomonas aeruginosa respiratory infections: A systematic literature review of the real-world evidence. | 2021 | Life |
Systematic literature review of real-world evidence of ceftolozane/tazobactam for the treatment of respiratory infections. | 2021 | Infectious Disease and Therapy |
Evaluating the clinical effectiveness of new beta-lactam/beta-lactamase inhibitor combination antibiotics: A systematic literature review and meta-analysis. | 2021 | Antimicrobial Stewardship & Healthcare Epidemiology |
Ceftolozane-tazobactam combination therapy compared to ceftolozane-tazobactam monotherapy for the treatment of severe infections: A systematic review and meta-analysis. | 2021 | Antibiotics |
The use of ceftolozane-tazobactam in the treatment of complicated intra-abdominal infections and complicated urinary tract infections-A meta-analysis of randomized controlled trials. | 2020 | International Journal of Antimicrobial Agents |
Clinical cure rate and cost-effectiveness of carbapenem-sparing beta-lactams vs. meropenem for Gram-negative infections: A systematic review, meta-analysis, and cost-effectiveness analysis. | 2020 | International Journal of Antimicrobial Agents |
Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications. | 2020 | International Journal of Antimicrobial Agents |